Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,047 | -23,789 | -94,654 | -89,880 | -59,627 |
| Depreciation Amortization | 1,569 | 773 | 3,398 | 2,558 | 1,720 |
| Accounts receivable | -62 | -71 | N/A | 1,208 | 686 |
| Accounts payable and accrued liabilities | 282 | -3,616 | 2,766 | 323 | 2,328 |
| Other Working Capital | 588 | -7,204 | -5,517 | -6,111 | -1,507 |
| Other Operating Activity | -1,617 | -2,994 | -29,058 | -80 | 205 |
| Operating Cash Flow | $-59,287 | $-36,901 | $-123,065 | $-91,982 | $-56,195 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,409 | -25,513 | 68,426 | 30,031 | 23,511 |
| PPE Investments | -234 | -235 | -1,241 | -567 | -239 |
| Investing Cash Flow | $7,175 | $-25,748 | $67,185 | $29,464 | $23,272 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -57 | -53 | -291 | -216 | -142 |
| Common Stock Issued | 144 | N/A | 119,979 | 128,179 | 109 |
| Common Stock Repurchased | N/A | N/A | -81 | -81 | N/A |
| Other Financing Activity | 0 | 0 | 11,438 | 13,866 | -283 |
| Financing Cash Flow | $87 | $-53 | $131,045 | $141,748 | $-316 |
| Beginning Cash Position | 170,553 | 170,553 | 95,388 | 95,388 | 95,388 |
| End Cash Position | 118,528 | 107,851 | 170,553 | 174,618 | 62,150 |
| Net Cash Flow | $-52,025 | $-62,702 | $75,165 | $79,230 | $-33,238 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,287 | -36,901 | -123,065 | -91,982 | -56,195 |
| Capital Expenditure | -234 | -235 | -1,241 | -567 | -239 |
| Free Cash Flow | -59,521 | -37,136 | -124,306 | -92,549 | -56,434 |